Target intelligence / Profile preview

ITPKB antisense RNA 1 (ITPKB-AS1)

Target
ITPKB-AS1
Molecular classification
Long noncoding RNA, Antisense RNA
01

Overview

ITPKB antisense RNA 1 (ITPKB-AS1) is classified as an antisense long noncoding RNA gene located on chromosome 1q. It is annotated in genomic databases (LNCipedia, GeneCards, WikiGenes) as a non-protein-coding RNA transcribed from the opposite strand of the ITPKB protein-coding gene. It possesses at least three transcript isoforms, but no functional studies, disease linkages, or drug interactions have been described so far[1][3][4][13]. There is nothing obviously misspelled about the entry, but "ITPKB antisense RNA 1" is not a standard therapeutic target such as a receptor, enzyme, transporter, or structurally defined RNA with known biological or pharmacological function. The is_target flag is set to false because antisense lncRNAs such as ITPKB-AS1 are generally not the molecule being directly targeted in drug discovery; rather, they are sometimes studied for their potential regulatory roles or biomarker value, which is not described here. The is_incorrect flag is set to true due to missing information, lack of evidence for a defined function, and the molecule not fitting into recognized target classes relevant for therapeutic drug development. If information emerges showing ITPKB-AS1 has a defined function, disease relevance, or druggability, this assessment should be revisited. As of now, it is best categorized as an uncharacterized antisense lncRNA with no evidence for direct druggability or a mechanistic disease role[1][4].

02

Biological functions

Unknown/Other. There is no currently available literature linking it to major biological functions
03

Disease associations

Unknown/Other. There are no well-characterized disease associations or implications as a driver or modulator in specific pathologies

Beyond the preview

Go deeper on ITPKB antisense RNA 1 (ITPKB-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ITPKB antisense RNA 1 (ITPKB-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call